Isle of Wight NHS Trust.
Clin Med (Lond). 2012 Dec;12(6):513-6. doi: 10.7861/clinmedicine.12-6-513.
Three documents have been produced in an attempt to increase the number of organs available for transplant: a National Institute for Health and Clinical Excellence (NICE) clinical guideline, a British Medical Association (BMA) report and a Welsh Government white paper. All three are ethically flawed: NICE and the BMA recommend that whenever there is intention to withdraw life-sustaining treatment and death is expected, patients should instead be stabilised to assess for donation. This is contrary to patients' best interests, the principles of mental capacity legislation and current criteria for accessing intensive care units. Regarding consent, the BMA and Welsh Government recommend an 'opt-out' policy, but consent in law requires information and cannot be 'presumed' or 'deemed' on the basis of failure to express or register 'opting out'. The language of all three proposals is manipulative, and patient trust may be undermined because the doctor's attention must move from the interests of the patient to those of the unknown organ recipients.
为了增加可用于移植的器官数量,已经生成了三份文件:一份英国国家卫生与临床优化研究所(NICE)临床指南、一份英国医学协会(BMA)报告和一份威尔士政府白皮书。这三份文件在伦理上都存在缺陷:NICE 和 BMA 建议,只要有意图撤回维持生命的治疗并预计死亡,就应稳定患者以评估捐赠。这违背了患者的最大利益、精神能力立法原则和目前进入重症监护病房的标准。关于同意,BMA 和威尔士政府建议采用“选择退出”政策,但法律上的同意需要信息,并且不能基于未表达或登记“选择退出”而“假定”或“视为”。这三个建议的措辞都是操纵性的,可能会破坏患者的信任,因为医生的注意力必须从患者的利益转移到未知器官接受者的利益。